Serynth Genital Warts Remover

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common warts characterized by a rough, cauliflower-like appearance.

Limitations of Use: This drug is not intended for the treatment of warts located on the face, genitals, or mucous membranes.

Dosage and Administration

Healthcare professionals are advised to follow the outlined procedure for the application of the medication to ensure optimal results.

Initially, the affected area should be washed thoroughly. Soaking the area in warm water for approximately 5 minutes may facilitate the cleansing process. After washing, it is essential to dry the area completely to ensure proper adhesion of the medication.

A small amount of the medication should then be applied directly to cover each wart. It is important to allow the application to dry completely before proceeding with any further activities.

This application should be repeated twice daily as needed, with a maximum treatment duration of up to 12 weeks. Regular monitoring of the treatment area is recommended to assess the effectiveness and any potential side effects.

Contraindications

Use is contraindicated on irritated or infected skin, or in areas exhibiting redness. Additionally, the product should not be applied to individuals with diabetes or poor blood circulation due to the increased risk of complications. It is also contraindicated for use on birthmarks, warts with hair growth, or moles.

Warnings and Precautions

The product is intended for external use only. It is imperative to avoid contact with the eyes. In the event of accidental exposure to the eyes, it is recommended to rinse thoroughly with water for at least 15 minutes. Additionally, users should refrain from inhaling vapors associated with the product.

Healthcare professionals should advise patients who are pregnant or breastfeeding to consult with a qualified health professional prior to using this product to ensure safety for both the mother and child.

In cases of ingestion, immediate medical assistance should be sought, or the local poison control center should be contacted without delay.

Patients are advised to discontinue use and consult a healthcare provider if discomfort persists, ensuring that any adverse reactions are appropriately addressed.

Side Effects

Patients should be aware that the product is for external use only and must avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is recommended to rinse thoroughly with water for 15 minutes. Additionally, patients should refrain from inhaling vapors associated with the product.

If discomfort persists after application, patients are advised to stop use and consult a healthcare professional. This precaution is important to ensure safety and address any potential adverse reactions that may arise during use.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Serynth Genital Warts Remover (salicylic acid 17% genital warts remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or a poison control center should be contacted.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is essential to evaluate the potential risks and benefits associated with its use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, careful consideration and professional guidance are recommended for lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of available data.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or a medical toxicologist may also be beneficial in managing the case effectively.

It is crucial to document all findings and interventions in the patient's medical record to ensure continuity of care and facilitate further management.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical help or contact a poison control center if the product is swallowed.

Patients should be informed that the product should not be applied to irritated or infected skin, or to areas that are reddened. Additionally, it should not be used on birthmarks, warts with hair growth, or moles, particularly in individuals who are diabetic or have poor blood circulation.

Healthcare providers should instruct patients to stop using the product and consult a doctor if discomfort persists after application.

For patients who are pregnant or breastfeeding, it is essential to recommend consulting a health professional before using the product to ensure safety for both the patient and the child.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. After opening, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

Patients who are pregnant or breastfeeding should consult a health professional prior to use. No further information is available regarding laboratory tests, abuse potential, route, method, or frequency of administration, as well as postmarketing experience.

Drug Information (PDF)

This file contains official product information for Serynth Genital Warts Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)